Visual Performance Investigation of Two Toric Soft Contact Lenses

NCT ID: NCT01858701

Last Updated: 2014-10-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the amount of coma as measured by aberrometry induced by two silicone hydrogel toric lenses in astigmatic participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Error Astigmatism Myopia Hyperopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AO for Astig / Biofinity Toric

Lotrafilcon B toric contact lenses worn in Period 1, followed by comfilcon A toric contact lenses in Period 2, as randomized. Each product will be worn bilaterally on a daily wear basis for 30 days, removed nightly. A minimum 1-day washout of no contact lens wear will precede each wear period.

Group Type OTHER

Lotrafilcon B toric contact lens

Intervention Type DEVICE

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Comfilcon A toric contact lens

Intervention Type DEVICE

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Biofinity Toric / AO for Astig

Comfilcon A toric contact lenses worn in Period 1, followed by lotrafilcon B toric contact lenses in Period 2, as randomized. Each product will be worn bilaterally on a daily wear basis for 30 days, removed nightly. A minimum 1-day washout of no contact lens wear will precede each wear period.

Group Type OTHER

Lotrafilcon B toric contact lens

Intervention Type DEVICE

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Comfilcon A toric contact lens

Intervention Type DEVICE

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lotrafilcon B toric contact lens

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Intervention Type DEVICE

Comfilcon A toric contact lens

Commercially available, silicone hydrogel contact lens for correction of astigmatism

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AIR OPTIX® for ASTIGMATISM Biofinity® Toric

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sign informed consent;
* Wears toric soft contact lenses;
* Can be successfully fit with study lenses within the power ranges available;
* Has cylinder of ≥ -0.75 diopter in both eyes;
* Has correctable vision of at least 0.1 (logMAR) or better in each eye at distance with both study lenses;
* Willing and able to wear study lenses on a daily wear basis for at least 5 days a week, minimum 8 hours per day, and attend all study visits;

Exclusion Criteria

* Any ocular condition that would contraindicate contact lens wear;
* Use of medications for which contact lens wear could be contraindicated;
* Monocular (only 1 eye with functional vision) or fit with 1 lens;
* History of herpetic keratitis, ocular surgery, or irregular cornea;
* Known sensitivity to the diagnostic pharmaceuticals to be used in the study;
* Requires presbyopic correction;
* Use of rewetting/lubricating eye-drops more than twice a day;
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jessie Lemp, MS

Role: STUDY_DIRECTOR

Alcon Research

Lyndon Jones, PhD

Role: PRINCIPAL_INVESTIGATOR

School of Optometry and Vision Science

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P/438/13/L

Identifier Type: -

Identifier Source: secondary_id

A01335

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.